1-5 of 5
Martin Homering
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quantitative Benefit–Risk Assessment of Rivaroxaban for the Prevention of Venous Thromboembolism.

Bennett Levitan, MD, PhD, Zhong Yuan, MD, PhD, Alexander GG Turpie, MD, Richard J Friedman, MD, Martin Homering, MSPH, Jesse A Berlin, ScD, Scott D Berkowitz, MD, FACP, Peter M DiBattiste, MD, FACC
Journal: Blood
Blood (2009) 114 (22): 169.
https://doi.org/10.1182/blood.V114.22.169.169
Published: 2009
Journal Articles

Effects of Age, Weight, Gender and Renal Function in a Pooled Analysis of Four Phase III Studies of Rivaroxaban for Prevention of Venous Thromboembolism after Major Orthopedic Surgery

Kenneth A. Bauer, MD, Martin Homering, Scott D. Berkowitz, MD, FACP
Journal: Blood
Blood (2008) 112 (11): 436.
https://doi.org/10.1182/blood.V112.11.436.436
Published: 2008
Journal Articles

A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effect on Symptomatic Venous Thromboembolism, Death, and Bleeding

Alexander GG Turpie, MD, Michael Rud Lassen, MD, Ajay K Kakkar, PhD, Bengt Eriksson, MD, PhD, Frank Misselwitz, MD, Tiemo Joerg Bandel, MD, Martin Homering, Torsten Westermeier, PhD, Michael Gent, DSc
Journal: Blood
Blood (2008) 112 (11): 36.
https://doi.org/10.1182/blood.V112.11.36.36
Published: 2008
Journal Articles

A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effects of Specified Co-Medications.

Bengt Eriksson, MD, Alexander GG Turpie, MD, Michael Rud Lassen, MD, Ajay K Kakkar, PhD, Frank Misselwitz, MD, Tiemo Joerg Bandel, Martin Homering, Torsten Westermeier, Michael Gent, MD
Journal: Blood
Blood (2008) 112 (11): 1986.
https://doi.org/10.1182/blood.V112.11.1986.1986
Published: 2008
Journal Articles

Thromboprophylaxis after Orthopaedic Surgery with an Oral, Direct Factor Xa Inhibitor: Pooled Results of Two Phase Iib Clinical Trials.

Alexander G.G. Turpie, MD, Kenneth Alan Bauer, MD, Lars Borris, MD, Ola E. Dahl, MD, PhD, William D. Fisher, MD, Michael Gent, MD, PhD, Sylvia Haas, MD, Menno V. Huisman, MD, PhD, Ajay K. Kakkar, MD, PhD, Peter Kälebo, MD, PhD, Louis M. Kwong, MD, Martin Homering, PhD, Frank Misselwitz, MD, PhD, Bengt I. Eriksson, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 277.
https://doi.org/10.1182/blood.V106.11.277.277
Published: 2005